A novel blood-saving plan for less-invasive primary total hip replacement.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 19298018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We conducted a quality improvement program to examine the effect of a blood-saving plan during primary total hip replacement (THR) performed using a nonvascular less invasive approach (LI-THR) and compared the results with historical control subjects. Erythropoietin and tranexamic acid (TA) were administered for selected patients. Analysis of 221 (study group) and 186 (historic group) LI-THRs showed reductions in total blood loss by 20% in a group of 133 patients compared to a control group of 82 patients who did not receive TA. This novel blood plan for LI-THR changed practice, improved quality of care, and allowed all patients to remain blood transfusion free.
Medical subject headings
- Arthroplasty, Replacement, Hip
- Blood Transfusion
- Hip Prosthesis
- Postoperative Hemorrhage
Anatomy
- hip